The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation

Yien Che Tsai1, Arnulfo Mendoza, Jennifer M Mariano

  • 1Laboratory of Protein Dynamics and Signaling, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, USA.

Nature Medicine
|November 27, 2007
PubMed

Insights

This study reveals that gp78 E3 ubiquitin ligase promotes sarcoma metastasis by degrading the KAI1 metastasis suppressor. Inhibiting gp78 increases KAI1 levels, reducing cancer spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Metastasis is the main cause of cancer mortality, particularly in sarcomas.
  • Mechanisms of metastasis, especially in sarcomas, are poorly understood.
  • Metastasis suppressor proteins' functions and regulation are not well characterized.

Purpose of the Study:

  • Investigate the role of gp78 (AMFR/RNF45) in sarcoma metastasis.
  • Determine if gp78's E3 ligase activity is required for its prometastatic function.
  • Elucidate the mechanism by which gp78 influences metastasis, focusing on its interaction with metastasis suppressors.

Main Methods:

  • Assessed the role of gp78 expression in human sarcoma metastasis.
  • Examined the requirement of gp78's E3 ligase activity for metastasis.
  • Investigated the interaction between gp78 and the KAI1 (CD82) metastasis suppressor.
  • Analyzed KAI1 protein levels and sarcoma cell metastatic potential upon gp78 modulation.
  • Confirmed the inverse relationship between gp78 and KAI1 in human sarcoma tissues.

Main Results:

  • Gp78 expression causally promotes metastasis in aggressive human sarcoma.
  • Gp78's prometastatic activity is dependent on its E3 ligase activity.
  • Gp78 targets the transmembrane metastasis suppressor KAI1 for degradation.
  • Suppressing gp78 increases KAI1 abundance and reduces tumor cell metastatic potential.
  • Concomitant suppression of KAI1 largely blocks the effect of gp78 suppression on metastasis.

Conclusions:

  • Gp78 acts as a prometastatic factor in human sarcoma by targeting KAI1 for degradation.
  • This study demonstrates post-translational downregulation of a metastasis suppressor by its ligase.
  • Results highlight a novel mechanism of metastasis regulation in sarcomas, distinct from genetic loss of suppressor genes.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...